Status:

COMPLETED

Virtual Reality a Novel Screening and Treatment Aid in Attention Deficit Disorder

Lead Sponsor:

Shaare Zedek Medical Center

Conditions:

ADHD

Eligibility:

All Genders

10-20 years

Phase:

PHASE2

Brief Summary

Using a virtual reality program in screening and treatment of ADHD.

Detailed Description

Virtual Reality is a novel program designed to imitate a real classroom environment including various distractions. It includes a head monitor to track eye movements Children aged 10-20 years with ADH...

Eligibility Criteria

Inclusion

  • Clinical diagnosis of ADHD-DSM4 criteria AGE 10-20 YEARS normal neurological examination IQ\>80

Exclusion

  • ABNORMAL NEUROLOGICAL STATUS

Key Trial Info

Start Date :

August 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2007

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT00364702

Start Date

August 1 2006

End Date

July 1 2007

Last Update

August 17 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Shaari Zedek Pediatric Neurology Unit

Jerusalem, Israel, 91031

Virtual Reality a Novel Screening and Treatment Aid in Attention Deficit Disorder | DecenTrialz